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Pain and distress are central topics in legislation, regulations, and standards regarding the use 
of animals in research. However, in practice, pain has received greatly increased attention in 
recent years, while attention to distress has lagged far behind, especially for distress that is not 
induced by pain.  A contributing factor is that there is less information readily available on 
distress, including practical information on its recognition, assessment and alleviation.  
 
This chapter attempts to help fill that void by reversing the usual pattern and giving greater 
attention to distress than to pain.  In addition, we also bypass the pain versus distress 
dichotomy by adopting a holistic treatment of adverse effects, i.e., not parsing distress and pain, 
by providing guidance on how to assess deviations from normality through tools such as score 
sheets.  Our aim is to provide practical information to IACUCs, scientists, technicians and 
animal care personnel. 
 
We organize the chapter according to specific research areas and case studies.  However, the 
principles and approaches are readily generalized to other research areas.   
 
Karas begins by examining surgical competence and the impact of variation in surgical skill on 
post-surgical pain and distress, as well as on research outcomes. She discusses the surgical 
stress syndrome and ways it can be diminished.  Drawing on the field of surgery in human 
medicine, Karas also provides recommendations on the various ways that surgical skills can be 
evaluated and enhanced, and that surgical outcomes can be improved. 
 
Leach discusses his use of aversion studies to sort out the controversy over the use of carbon 
dioxide as a euthanasia agent in mice and other animals.  His findings suggest that carbon 
dioxide alone is not an appropriate euthanasia agent.  More generally, Leach indicates that 
indicators of pain and distress must be selected and interpreted with care, to avoid generating 
equivocal results and endless controversy.  His work also demonstrates that valuable 
information on pain and distress can be obtained without causing more than momentary pain or 
distress to research animals.  
 
Andrutis tackles the difficult issue of how to address distress in infectious disease models—both 
acute and chronic.  He highlights the importance of understanding how the disease will likely 
affect the animal, by gathering data on clinical signs and behavior, including activity patterns, 
with the aid of tailored score sheets and measurements such as body temperature and weight.  
The key approach to amelioration of adverse effects consistent with study aims is the 
determination of humane endpoints and their implementation. Andrutis concludes that the pace 
of progress in refining infectious disease research has been slow.  We hope his contribution to 
this chapter will encourage an expansion of this effort, both for the sake of animal welfare and 
research quality.  
 
Conlee discusses ways in which the pain and distress associated with polyclonal antibody 
production can be minimized. Key issues include the choice of adjuvant, adjuvant volume, and 
injection sites, as well as the use of booster injections. This case study offers a good example of 
how seemingly minor refinements can greatly reduce pain and distress associated with 
commonly used procedures.  
 
Gluck provides information on how to address complex issues associated with animal research 
on psychopathology, using anxiety models as his frame of reference.  Psychopathology 
research on animals can often induce adverse states associated with distress, such as anxiety, 
fear or depression.  Like research on pain, the challenge becomes how to mitigate the impact of 
effects one may be seeking to induce, maintain, and study. This poses a clear challenge to 
those who must review or carry out psychological research, or care for the animals in such 
studies. Gluck poses probing questions that should be asked during development and review of 
these research models.  
 
Conlee, Stephens, and Rowan summarize a workshop held on the neglected field of refinement 
in toxicity testing. Production of guidelines regarding humane endpoints in toxicity testing 
(including for both acute and chronic testing) was a main goal of the workshop.  Experts provide 
information on how to monitor animals used in toxicity testing for pain and distress, such as use 
of telemetry, clinical signs, and gene expression, as well as the use of postmortem pathology in 
order to determine humane endpoints for future study. Specific aspects of toxicity testing are 
also addressed, such as dosing volume and routes and frequency of administration. Not only is 
current knowledge assessed, but future areas of research are identified as well.  
 
Finally, Appendix A provides useful references in terms of addressing pain and distress caused 
by certain areas of research as well as common procedures.  
 
 
Effect of surgical technical skill on pain and distress in animals 
Alicia Karas, DVM 
Tufts University 
 
In the absence of analgesics, surgical tissue manipulation under anesthesia typically causes 
pain upon awakening or shortly thereafter. Pain can last a day or less, or can continue in some 
cases for months to years (Perkins and Kehlet 2000). Although it seems reasonable to assume 
that the tissue handling skills of the surgeon have a major effect on the degree of pain caused 
by a given surgery, there has been seemingly little direct study of the impact of surgical skill 
level or the extent of surgical training on postoperative pain in any species. Yet, many of us who 
have seen the same painful procedure performed by both a novice and by an experienced 
person (such as intravenous catheter placement, or ovariohysterectomy in a veterinary school 
training laboratory), have noted there are often dramatic differences in the amount of pain 
associated with the same surgeries performed by those with different levels of surgical 
experience. 
 
In laboratory animal research, the individuals who perform surgery may have varied levels of 
training, ranging from no prior experience to postgraduate surgical specialty competency. In 
larger animal species such as dogs or swine, especially in the case of relatively complicated 
procedures, surgery will often be performed by individuals with a significant amount of training. 
However, the typical investigator using rodent surgery models (for example, craniotomy, 
ovariohysterectomy, catheter or telemeter implantation) is unlikely to have come to the 
laboratory with any significant training or background in performing surgical techniques. In 
addition, those experienced with surgery in one species (i.e. goat or human) may find that tissue 
handling requirements are very different in another species (i.e. mouse), and this difference may 
be problematic. The extent of training of investigators in animal manipulations is of considerable 
importance if pain and distress are indeed greater in animals subjected to less skillful handling 
or surgery.  
In the absence of direct evidence that surgical skill level influences the amount of pain or 
distress an animal feels post-operatively, it is possible to approach the subject by examining 
three areas of information: 
 the impact of degree of surgical trauma on pain and other morbidities, 
 surgical training of MDs, and  
 outcome measures. 
 
Trauma and surgery directly cause pain, but the neural input of painful stimuli also initiates a 
series of hormonal and metabolic changes known as the “surgical stress response” which may 
further contribute to both pain and morbidity. General anesthesia and surgery activate an 
endocrine state of catabolism (stress response), the extent and duration of which correspond 
positively to the magnitude and duration of the procedure and which culminates in loss of body 
weight and muscle mass. At the same time, certain alterations in the state and function of the 
immune system occur (Desborough 2000). Tissue injury, including surgical wounds, trauma, 
and sepsis, can result in profound effects on the patient’s immune function – principally via 
increases in circulating cytokine levels.  Cytokines are plasma proteins produced by cells of the 
immune system.  They play major roles in mediating inflammation in the damaged tissue as well 
as in modifying immunocyte surveillance and wound healing. Certain cytokines are intricately 
intertwined with the induction of the painful state, in that cytokines play a role in pain 
transmission, transduction, and perception of pain signals (Shafer 2003). Cytokines are also 
thought to be responsible for the feelings of malaise and for fever after surgery as well (Sheeran 
and Hall 1997).  
 
Although believed to be strategically adaptive for the animal, the surgical stress response and 
the production of the cytokine response can be manipulated in a number of ways to decrease its 
magnitude, as excessive cytokine responses are believed to contribute to organ dysfunction and 
acute and chronic pain after surgery (Kehlet 2000, Beilin et al. 2003). Attempts to reduce the 
magnitude of stress and cytokine responses are aimed principally at reducing morbidity (in 
studies of human postoperative complications the improvement in outcome includes such 
measures as length of hospital stay or incidence of postoperative ileus, pneumonia, myocardial 
ischemia). Effective cytokine response reduction methodologies work by preventing pain, 
modifying fear and anxiety states, and reducing the invasiveness of the surgical procedure 
(Kehlet 2000, Kiecolt-Glaser et al 1998, Beilin et al 2003, Shafer 2003).  Good examples exist of 
the positive effects of reducing pain.  
 
Decreased immune surveillance after cancer surgery appears to enhance the metastatic 
potential for cancers in both humans and in animal models. Interventions that inhibit pain, such 
as administration of morphine, or spinal blockade, have been shown in many animal studies to 
reduce uptake and retention of injected tumor cells (Beilin et al 2003, Ben-Eliyahu et al 1999, 
Bar-Yosef et al 2001). The exact relationship between pain, immune function and administration 
of analgesics is currently the subject of intense investigation, particularly in the field of surgical 
oncology.  
 
Minimization of tissue trauma reduces post-surgical pain, and it is generally accepted that 
reducing the size of the incision reduces the amount of pain felt by the patient.  In smaller 
patients or animal subjects, incision length is often described as “small”, thereby implying that it 
is less consequential to the patient.  However incision size should be considered as proportional 
to body size, so in small patients incisions are often relatively large in order to facilitate access 
to the surgical site by comparatively large fingers and instruments. Minimally invasive surgery is 
an emerging field, gaining popularity for the reduced pain, convalescence, and severity of 
impact upon the patient that it apparently causes. Rather than “open” techniques which involve 
an incision that permits manual manipulation, and thus large amounts of surgical trauma, in 
minimally invasive surgery, manipulations are performed by means of small bore rigid or flexible 
instruments (laparoscopes, endoscopes) inserted through small stab incisions. Again, the 
relationship between pain, tissue damage and immune function is important here. Minimally 
invasive techniques are widely cited to decrease postoperative pain in both humans and animal 
models (Walsh et al 1999).  A model to study standard versus minimally invasive laparotomy 
techniques in mice showed correspondingly lower production of certain deleterious cytokines in 
the mice having the less invasive procedure, thereby lessening the degree of 
immunosuppression (Iwanaka et al 1997).   
 
Chronic pain states are documented to result from a number of major surgical procedures in 
humans, including amputation of limbs, thoracotomy, mastectomy, and hernia repair. Chronic 
pain states may develop in up to 50 – 81% of such surgeries (Perkins and Kehlet 2000). A 
number of perioperative factors were found to predict the generation of a chronic pain state: 
these include pre-existing pain, repeat surgery, surgical techniques where nerve damage might 
occur, acute postoperative pain, and anxiety (Perkins and Kehlet 2000). This indicates that 
methods to combat acute pain and reduce anxiety, as well as methods to reduce the extent of 
surgical trauma, could ostensibly reduce both short and long term pain in animals. 
 
The literature about teaching / learning of surgical skills by MD trainees appears to support the 
premise that complication rates and duration of surgery are related to the number of procedures 
performed and the quality of surgical training. In other words, practice makes a competent 
surgeon, reducing procedure duration and improving outcome. Weise et al. (2004) examined 
complication and outcome rates for a surgical procedure dependent on the level of surgical 
training, based on number of cases performed prior to the assessment. This study found that 
more experienced surgeons (those having performed 10 times the number of surgeries 
compared to the less experienced group) had a complication rate of 2.2% versus 10.7% for the 
less experienced group.  The investigators noted that some of the recorded complications were 
associated with greater initial postoperative pain. Georgeson and Owings (2000) cited the 
inverse relationship between duration of procedure and surgical experience (number of 
surgeries performed) in MD surgeons; when surgeons had performed fewer than 10 of a 
particular endoscopic procedure, the duration of that surgery was roughly double that of 
surgeons who had performed the same surgery 40 times. If surgical time increases 
postoperative pain due to increased tissue handling, then one might surmise that as surgeons 
move along the learning curve for a technique, pain from a surgery will be reduced.  
 
In studies on the effects of surgery on mice in my own laboratory, we found that the average 24-
hour post-operative weight loss in a study where the surgeon was a presumably competent 
graduate student was 12%.  However, in a follow-up study where the surgeon was very 
experienced, the average 24-hour post-operative weight loss was just 7%; this points to the 
possibility of tracking not just the duration of a specific surgery but also post-operative weight 
loss as a measure of surgical skill. 
 
It is not surprising that both the quality of training and a surgeon’s innate visuospatial and 
psychomotor skills are essential components of surgical proficiency (Khan et al, 2003).  Keeping 
in mind that the studies cited in this review center upon MDs with at least several years of 
postgraduate training in surgery, it is important to consider whether performing a surgery 5 to 10 
times leads to sufficient skill in a novice investigator with little to no background in anatomy or 
surgery. This leads to the question of how competency in laboratory animal surgery should be 
acquired and assessed. Technical surgical skill is fundamental to both accurate science and 
humane science if skill correlates with outcome, producing a viable and useful experimental 
model, and if skill correlates with degree of postoperative pain.  If, for example, the learning 
curve is steep over the first 10 – 20 surgeries, then lack of skill in the investigator-surgeon will 
be expected to introduce a significant experimental treatment-order bias. Models for training and 
evaluating surgeons can include actual patients, surrogate patients (live animals), cadavers, 
and inanimate models. Datta et al. (2004) concluded that assessments of technical skill in 
surgical trainees using inanimate (bench top) models correlated well with actual surgical 
performance on humans, using a structured system of evaluation, the “objective structured 
assessment of technical skill” or OSATS. No comparable system of tracking or assessing 
competency of individuals performing surgery on laboratory animals is currently advocated.  If, 
however, a uniform animal subject population is felt to be critical to experimental investigation, 
then the development of methods of assessment of surgical skill as well as methods to 
subjectively evaluate animals/outcomes after surgery are important in order to detect and 
prevent unwelcome variation in experimental models.  
 
Taking all of the above into account, it can be argued that the end result from a surgical 
procedure in a laboratory animal model may depend significantly upon the degree of pain or 
invasiveness of a procedure, which may depend upon the skill of the surgeon, which in turn 
depends upon the quality and quantity of training, as well as upon innate characteristics of the 
surgeon.  Scientists frequently balk at the introduction of new methods, such as anesthesia, 
analgesics, or environmental enrichment to prevent distress, worried that these methods 
increase the risk of variability, potentially making the experimental results less valid, unable to 
be replicated, or less acceptable by peer review.   A case can be made therefore, that 
inadequate surgical skill, or unevenness in the exposure of animals to handling by a surgeon on 
the steep portion of a technical learning curve, has the potential to adversely affect research 
results in a similar way.  
 
It is essential for scientists to be aware of the effects of surgery (pain, immunomodulation, 
endocrine responses) on animals. To avoid variability in results, there is a need for a general 
recognition of the effects of skill level on outcome, to develop methods to evaluate and track 
surgical skill level, and to more carefully monitor animals to detect when surgical pain or distress 
are above what is considered to be normal or anticipated, given the manipulation. Such a 
refinement of scientific method might also be expected to reduce pain and distress in animal 
subjects, particularly if training on procedures makes use of inanimate models or simulations 
and cadavers as has proved effective.  Investigators would then proceed to survival surgeries 
only when a certain level of competency is reached. 
 
 
Carbon dioxide euthanasia: example of aversion techniques 
Matthew C. Leach, PhD 
University of Newcastle 
 
Carbon dioxide exposure is a recommended and widely used method of euthanasia for many 
laboratory and farm animal species (Blackshaw et al., 1988; Blackmore, 1993; Coenen et al., 
1995; EU Working Party, 1996, 1997; Danneman et al., 1997; Kohler et al., 1999; van Luijtelaar 
& Coenen, 1999; Hackbarth et al., 2000).  It is considered by many regulatory organizations 
(e.g. AVMA 2000; Home Office 1997) to fulfil the criteria for an effective agent of euthanasia, as 
it is cost effective, readily available, aesthetically acceptable to humans, and can be used to kill 
many animals simultaneously.  However, questions remain over whether carbon dioxide can 
induce unconsciousness and death humanely, which is one of the most important, and yet often 
forgotten, characteristics of agents of euthanasia.  To be considered humane, an agent must 
minimize any suffering associated with induction to unconsciousness, i.e. animal’s initial 
perception of an agent, the pain and distress that is experienced before loss of consciousness, 
and the time taken to induce unconsciousness.  Although carbon dioxide induces a rapid loss of 
consciousness at concentrations above 40% (Coenen et al., 1995; Kohler et al., 1999; van 
Luijtelaar & Coenen, 1999) and death above 70% (Iwarsson & Rehbinder, 1993), its ability to 
induce unconsciousness humanely remains extremely controversial. 
 
The controversy surrounding carbon dioxide stems from the contradictory findings of the 
previous studies assessing the humaneness of carbon dioxide.  Some authors have concluded 
that carbon dioxide concentrations high enough to cause loss of consciousness and death 
provide a non-distressing induction for both rodents (Blackshaw et al., 1988; Hewett et al., 1993; 
Smith & Harrap, 1997; Kohler et al., 1999; Hackbarth et al., 2000) and other species (Mullenax 
& Dougherty, 1963), whereas others have concluded that such concentrations cause 
considerable distress before loss of consciousness in both rodents (Iwarrson & Rehbinder, 
1993; Coenen et al., 1995; Ludders et al., 1999) and other species (Lucke, 1979; Raj & 
Gregory, 1994; Raj & Whittington, 1995; Raj & Gregory, 1995; van Luijtelaar & Coenen, 1999).  
The contradictory nature of these studies seems to relate to the fact that they used only a 
limited number of essentially the same behavioral measures to assess aversion, and that there 
were considerable differences in the interpretation of these behaviors between studies 
(Danneman et al., 1997), leading to a diversity of conclusions regarding their implications for 
welfare. 
 
The potential distress associated with carbon dioxide has been attributed to irritation of the 
nasal mucosal membranes (Lucke, 1979; Ewbank, 1983; Iwarrson & Rehbinder, 1993) and 
hypoxia and hypercapnia causing breathlessness and hyperventilation (Hewett et al., 1993; Raj 
& Gregory, 1995; Raj & Whittington, 1995; Lambooij et al., 1999; Ludders et al., 1999; van 
Luijtelaar & Coenen, 1999).  As carbon dioxide exposure is considered by many to offer an 
economic and rapid euthanasia technique, a number of modifications have been suggested to 
reduce these potential problems.  First, both placing animals into a rising verses static 
concentration of carbon dioxide (Kohler et al. 1999), and introducing carbon dioxide after 
animals have been placed into a chamber, have been suggested to induce the loss of 
consciousness before animals are exposed to higher concentrations that may associated with 
pain and distress.  Secondly, humidification has been suggested to reduce irritation resulting 
from the dry nature of the gas (MacArthur, 1978; Mouton et al., 2001).  Thirdly, the addition of 
exogenous oxygen has been suggested to reduce the level of potentially distressing hypoxia 
experienced before loss of consciousness (Anon, 1967; Iwarsson & Rehbinder, 1993; Coenen 
et al., 1995; EU Working Party Report, 1996; Danneman et al., 1997; Smith & Harrap, 1997; 
Kohler et al., 1999).  Finally, combinations of low carbon dioxide (30%) and high argon 
concentrations (60%) have been tested recently with farm animal species.  This combination is 
thought to be as efficient as and more humane than carbon dioxide alone (Raj & Gregory, 1994; 
Raj & Whittington, 1995; Raj, 1999), as it is suggested to cause unconsciousness and death by 
hypoxia without causing the breathlessness and painful irritation of the mucous membranes (Raj 
& Gregory, 1994; Lambooij et al., 1999; van Luijtelaar & Coenen, 1999; Raj & Whittington, 1995; 
Raj, 1999). 
 
More recently the work of Leach et al., (2002a,b; 2003) has attempted to untangle the 
controversy surrounding the humaneness of carbon dioxide and to assess the extent of 
aversion associated with it, compared to the potentially more humane modifications and other 
alternative gaseous euthanasia agents.  These studies assessed aversion of laboratory rodents 
to carbon dioxide (humidified & non-humidified), argon, carbon dioxide-argon mixtures, carbon 
dioxide-oxygen mixtures, and volatile liquid anesthetics using a wide range of aversion 
measures in an attempt to gain a clearer insight into what an animal might experience, as 
opposed to what a human might interpret by observing animal behavior. These studies used 
measurements of an animal’s attempts to escape from and avoid the potentially noxious agents 
(dwelling time, numbers of occasions of withdrawal and re-entry), alongside the behavioral 
measures used to assess rodent aversion in previous studies. The results of this work have 
demonstrated that the behavioral measures that have formed the basis of almost all previous 
aversion studies are very poor measures of aversion, and therefore cannot be relied upon to 
effectively measure the animal’s reactions (aversion) to the agents.  This helps explain why the 
results of these studies are so contradictory.   
 
Alternatively, the measurements of the animal’s attempts to escape or avoid the noxious 
stimulus proved to be considerably more effective measures of the animal’s reaction.  These 
measures demonstrated that carbon dioxide caused considerable aversion and that an animal 
confined in an environment containing these gases is likely to suffer considerable pain and 
distress before unconsciousness occurs. Carbon dioxide caused significant aversion whether 
presented alone (humidified & non-humidified) or in combination with oxygen or argon (even at 
a low concentrations sufficient to induce a loss of consciousness, let alone those high enough to 
cause death). Most importantly, aversion was observed with these agents at very low 
concentrations, which are below those that will effectively induce unconsciousness and are 
likely to be reached very rapidly even with a slow rising concentration, as tested in some of the 
other studies (Fenwick & Blackshaw 1989; Kohler et al. 1999).  The remaining agents appear to 
be far less aversive than carbon dioxide and its combinations, with the volatile liquid anesthetics 
proving to be by far the least aversive agents tested. Argon induced aversion at a level between 
that of the anesthetics and carbon dioxide.  
 
The finding that carbon dioxide may cause considerable pain and distress before 
unconsciousness should perhaps not be surprising, as human and animal pain research has 
routinely used carbon dioxide as a noxious stimulus at similar concentrations to those 
recommended for euthanasia (Thurauf et al., 1991; Anton et al., 1992; Komai & Bryant, 1993; 
Peppel & Anton, 1993; Danneman et al., 1997).  This begs the question: how can an agent 
induce unconsciousness humanely and be a noxious stimulus at the same concentration?  
Humans report carbon dioxide exposure at levels sufficient to   cause unconsciousness in 
animals (above 40%), as ‘unpleasant and distressing’; levels sufficient to kill (above 70%) are 
described as ‘painful’ (Paton 1983; Gregory et al. 1990).  Based upon the current understanding 
of comparative anatomy and physiology of respiration and pain (Raj et al., 2004), and the fact 
that animals exhibit signs of aversion at similar concentrations to those of humans, it seems 
extremely likely that they experience similar distressing and painful sensations on exposure to 
carbon dioxide.  Therefore, carbon dioxide should not be used for euthanasia by this principle 
alone. 
 
The results of existing papers directly investigating the humaneness of carbon dioxide 
euthanasia in laboratory and farm animal species, and those that have assessed carbon dioxide 
exposure on human subjects, demonstrate that carbon dioxide in the form/s that it is currently 
used cannot induce unconsciousness, let alone death, without causing considerable degree of 
pain and suffering. A viable alternative to using carbon dioxide alone would be to use a volatile 
liquid anaesthetic (e.g. halothane or enflurane) in order to induce unconsciousness and then to 
subsequently kill the animals rapidly with carbon dioxide once the animals are unconscious 
(Leach et al., 2002a,b; Leach et al., 2003; Raj et al., 2004). 
 
 
The Refinement of Infectious Disease Research 
Karl A. Andrutis DVM, MS, DACLAM 
University of Florida 
 
Infectious disease research on animals can cause varying degrees of pain or distress as a 
consequence of exposing (challenging) the animals to infectious agents or their toxins and 
letting the resulting morbidity and mortality ensue.  Everyone presumes that a sick animal is in a 
state of reduced welfare but why does sickness produce a negative state?   Gregory (1998 & 
2004) and Maier and Watkins (1998) link the status of the immune system and “feeling” states in 
animals.  According to Gregory (1998), there are various “sickness behaviors” or responses that 
are common to a wide variety of diseases.  These include fever, hyperalgesia, reduced 
movement and appetite, social isolation, muscle catabolism and pain, and impaired memory 
and learning.  Behaviors such as isolation and rest intuitively would help prevent the spread of 
disease and promote healing while fever and fasting appear to suppress the pathogenicity of 
some micro-organisms.   
 
The behavioral responses have a physiological basis and are linked to the activity of certain 
cytokines – especially interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor (TNF).   
Maier and Watkins (1998) report that blocking the relevant cytokines prevents the characteristic 
sickness behaviors while injecting the same cytokines into healthy animals produces the full 
syndrome of responses.  IL-1 is the most potent in producing these behaviors and is strongly 
induced by the endotoxin, lipopolysaccharide.  The cytokines do not appear to cross the blood-
brain barrier and their effects on the CNS seem to be mediated in part by the vagus nerve.   
 
Kelley & Dantzer (2007), in a recent review, note that the newly-defined role of cytokines in a 
wide variety of systemic co-morbid conditions, ranging from chronic heart failure to obesity, may 
begin to explain changes in the mental state of such subjects. They continue that there are a 
number of pharmacological tools available to antagonize the detrimental actions of cytokines. 
 
Infectious disease research would seem to be an obvious opportunity for applying alternative 
methods especially refinements; however; progress in this area has been slow.  In this section, 
we briefly summarize the literature on refinement in infectious disease research, emphasizing 
the use of tailored score sheets and humane endpoints.  Other approaches, such as the use of 
sophisticated noninvasive imaging techniques that limit both animal suffering and sample sizes, 
are reviewed elsewhere (Contag, C.H. et al, 1995; Contag P.R., et al., 2008). 
 
As stressed by previous reviewers of refinement in infectious disease studies (Hamm 1995, 
Olfert and Godson 2000), the key ingredient to implementing effective monitoring strategies and 
humane endpoints is a cooperative, and possibly collaborative, working relationship between 
the principal investigator, the veterinary and animal care staff, and the Institutional Animal Care 
and Use Committee (IACUC) (Medina 2004). 
 
Although the consideration of alternative methods prior to performing animal studies is 
mandated by regulatory authorities (Public Health Service 2002, United States Department of 
Agriculture 2002), many scientists continue to view this requirement as intrusive and not 
beneficial to their work. Those scientists that have embraced the concept of alternatives view 
the development, evaluation, and implementation of alternative methods as identical to the 
refinements made in any scientific endeavor in which methods are modified to produce the 
highest quality results. 
 
The suggested approach to the development, evaluation, and implementation of alternatives in 
infectious disease research begins with resolving the philosophical differences regarding 
alternatives or, at least, coming to some agreement that refinement of animal use is compatible 
with good science and may, in fact, lead to better results. Once the principal investigator agrees 
that developing alternative methods is a worthy goal, the alternatives-related work can begin. 
 
The investigator should understand the pathogenic mechanisms by which the infectious agent 
or toxin acts on the animal. This understanding will assist in the identification of clinical signs or 
other physiological and behavioral parameters that should be monitored during the course of the 
study. The time course of pathogenesis will be critical to determine the logistical aspects of 
dosing and monitoring of the animals. Without this understanding, one needs to start with less 
specific indicators such as body weight, body condition score (Ullman-Cullere and Foltz 1999), 
activity levels and other simple behavioral assessments to identify criteria that would be 
indicative of morbidity. A good example of a relatively non-specific clinical sign to assess pain or 
distress is the recently described method for assessing stress in rats by scoring 
chromodacryorrhea (secretion of porphyrin-filled tears—commonly referred to as “red tears” or 
“bloody tears”) (Mason et al., 2004). Evaluation of activity patterns has been a useful parameter 
in infectious disease (Olfert and Godson 2000, Vlach et al. 2000) and other models (Karas et al. 
2001). 
 
One of the best ways to record and organize these assessments is by the use of a score sheet 
or monitoring form (Morton 2000, van der Meer et al. 2001). Development of a simple yet 
complete monitoring form for a given type of research is critical to the success of identifying 
determinants of a humane endpoint. The ease of use of the monitoring form will determine 
investigator compliance as well as the ability to interpret the data. Effort should be made at the 
beginning of the study to predict which parameters to assess and the method of scoring these 
parameters. The parameters and the scoring system may need to be modified as the study 
progresses and new information is obtained. Research and animal care staff must be trained to 
understand the clinical signs or other parameters being assessed and the basis of the scoring 
system. Review of the data collected on monitoring forms should occur frequently to assess its 
value and interpretation.  
 
A more complete understanding of the pathophysiology involved in the animal model might 
identify more specific parameters for monitoring animals. Studies involving acute infections or 
toxicity may require assessment of different parameters than models of chronic infections. 
Whereas weight loss and body condition score might be very useful parameters in a chronic 
model, they may be less useful or unchanged in an acute model. Assessment of particular 
organ systems may require training and skill in collecting samples for laboratory measurement 
and assessing clinical signs such as respiratory rate or effort. Remote monitoring of physiologic 
variables such as heart rate, blood pressure, and body temperature may also be performed with 
telemetry (Morton et al. 2003), implantable microchips, or infrared thermometer.  These are 
additional refinements that could be used, though they come at the “cost” of any pain or distress 
associated with their implantation and maintenance in the animals’ body. 
 
Body temperature has been used as a possible determinant of humane endpoints (Toth 2000, 
Olfert and Godson 2000). Some models of infectious disease have found body temperature to 
be predictive of mortality (Wong et al. 1997, Kort et al. 1998, Vlach et al. 2000, Warn et al. 
2003) while body temperature was found not to be a useful parameter in other models (Krarup 
et al. 1999). Furthermore, body temperature may or may not be altered during certain periods of 
an infection and must be assessed at the appropriate time during the course of the study. Other 
parameters may also vary during the course of infection and the timing of assessments may be 
critical to their value in identifying a humane endpoint. 
 
As mentioned, a thorough understanding of the pathophysiology of the animal model, 
determination of the parameters to be monitored, and the scoring system used are of critical 
importance in the process of developing humane endpoints. The real question in the search for 
a humane endpoint is the proximate cause of death. Many investigators believe that the cause 
of death is directly related to their experimental manipulation such as infection or toxicity. But 
this assumption is not enough to define a cause of death. Perhaps the cause of death is sepsis 
with its many physiological consequences ultimately resulting in shock and cardiovascular 
collapse. Or perhaps cardiovascular collapse is the result of prolonged inappetance and 
profound dehydration as a secondary effect of the infectious process, i.e., the sickness 
behaviors discussed earlier. Since most animal models do not include supportive care during 
the course of infection, this distinction may be very important, particularly in therapeutic studies 
where subtle differences may be critical. Identifying the proximate cause of death should assist 
in monitoring the critical parameters leading to morbidity and mortality. 
 
Davis has provided a case study of how to relieve symptoms of pain and distress in a disease 
model, experimental allergic encephalitis (EAS), through palliative care while also facilitating 
achievement of study objectives (Davis, 1999/2000). The investigator initially proposed a 
grading scale of EAE obtained in the published literature. This proposed scale simply indicated 
a grade that corresponded with specific clinical signs, with no mention of intervention. For 
example, the clinical signs for grade 3 were indicated as “partial hind limb paralysis,” with no 
mention of intervention/care.  
 
The veterinary staff then met with investigators to develop a mutually acceptable grading 
scheme that would meet study objectives, establish guidelines for intervention, and would not 
interfere with study goals. As a result, the clinical signs for grade 3 included “moderate 
paraparesis: inability to move one or both hindlegs, possible atonic bladder, noticeable gait 
disturbance.” Additionally, the intervention was specified as “food and water more accessible 
(feed pellets and fruit placed on floor of the cage), express urinary bladder, if needed, weigh 3 
times weekly, euthanize if > 20 percent weight loss.”  
 
As observational skills developed, they began categorizing mice in EAE grade 1 earlier and 
earlier, which resulted in more intense monitoring and nursing and a modified assessment chart. 
For example, the final grading scheme indicated clinical signs for grade 3 as “moderate 
paraparesis:  inability to move one or both hindlegs, noticeable gait disturbance, possible atonic 
bladders.” The corresponding intervention was “food and water more accessible (for example, 
feed mash placed on floor of cage, water bottle w/long sipper tube, and fruit as fluid 
supplementation). Express urinary bladder twice daily; give fluids, if necessary. Animals may 
need supplemental heat. Weigh at least three times per week. Euthanize if > 20 percent body 
weight loss.” 
 
The outcomes of this grading scheme effort were 
 
• Improved assessment and alleviation of animal pain and distress 
• Animals who lived longer, which allowed investigators to reach study endpoints.  
• Requests from the investigators for the observational data (i.e. weight) to correlate with 
their measurement of disease.  
The development, evaluation, and implementation of alternative methods in infectious disease 
research requires the cooperation of the principle investigator and research staff, the 
veterinarian and animal care staff, and the IACUC. The process of developing humane 
endpoints while meeting the scientific objectives of the research is dependent on the committed 
involvement of these individuals.  Key personnel ingredients for success include adequate 
training (to identify the appropriate parameters to monitor) and sufficient dedication to carry out 
monitoring at the appropriate time (often occurring after normal work hours).  The careful 
evaluation and interpretation of the monitoring data and its association with the time course of 
morbidity and mortality in the study will allow for improvements in refinement alternatives in 
infectious disease research. 
 
 
Polyclonal antibody production    
Kathleen Conlee, BS, MPA 
The Humane Society of the United States 
 
Polyclonal antibody (Pab) production has significant potential to cause animal pain and distress. 
However, this pain and distress may not be appropriately addressed because antibody 
production is only one procedure within a larger research objective, such as their application to 
vaccine quality control, diagnostic testing, cancer therapies, or immunological research. There 
are a number of steps involved with Pab production itself that likely cause pain and distress, 
including choice and volume of adjuvant, injection site, blood drawing, and use of booster 
injections.   
 
Production of antibodies in a human or nonhuman is achieved by injecting an adjuvant (antigen) 
that is recognized as foreign to the body in order to stimulate the immune system. Monoclonal 
antibodies are produced by cells that are derived from a single clone of an antibody-producing 
cell, whereas Pabs are derived from many different clones that will bind to many sites on the 
antigen; therefore they have decreased specificity in comparison with Mabs, but a range of 
differing avidities (i.e., strength of binding). Researchers seek to maximize antibody yield.  This 
aim can be viewed as in conflict with animal welfare, but this does not need to be the case.  
 
In order to address minimization of pain and distress associated with the various steps of Pab 
production, The Humane Society of the United States (HSUS) convened a workshop of 
international experts1 in the fields of antibody production, animal welfare, in vitro alternatives 
and/or regulatory compliance. The expert recommendations resulting from the workshop are 
summarized here (the entire manuscript from the workshop can be found on The HSUS website 
at 
http://www.hsus.org/animals_in_research/pain_distress/pain_and_distress_associated_with_pol
yclonal_antibody_production.html) and a sample score sheet for the assessment of animals 
used for polyclonal antibody production is included as well (see Table 1). Information that has 
                                                 
1 Workshop participants (and affiliation at that time) included: Vera Baumans, Ph.D. Karolinska Institute; 
Kathleen Conlee, M.P.A., The Humane Society of the United States; Wim A. deLeeuw, D.V.M., Ministry of 
Public Health in the Netherlands; Coenraad Hendriksen, D.V.M., Ph.D., Netherlands Vaccine Institute, 
Netherlands Center for Alternatives to Animal Use; David Johnson, D.V.M., advisor for Harlan, Inc.; John 
McArdle, Ph.D., Center for Alternatives Resources; David Morton, B.V.Sc., Ph.D., University of 
Birmingham; Norm Peterson, D.V.M., Johns Hopkins University; Jon Richmond, M.D., Ph.D., Home 
Office, United Kingdom; Margaret Rose, Ph.D., University of New South Wales; Andrew Rowan, Ph.D., 
The Humane Society of the United States; and Harold Stills, D.V.M., Wright State University School of 
Medicine.  
become available since the expert workshop will be discussed in this section as well. 
Importantly, the Institute for Laboratory Animal Research Journal devoted an issue to 
immunization procedures and adjuvants (ILAR Journal Volume 46, Number 3, 2005). 
 
Before the workshop participants tackled specific procedures and techniques involved with 
antibody production, all agreed that it was first important to emphasize that only experienced 
personnel should be allowed to engage in Pab production. Personnel must be able to assess 
the animals for distress and pain and handle animals appropriately--a general rule should apply 
to all procedures involving the use of animals.  
 
A. The workshop participants recommended utilizing the chicken egg yolk (IgY) technique for 
Pab production when possible. Polyclonal antibody production most commonly involves the use 
of rabbits given the relative ease of housing, handling and taking blood from these animals; 
however, guinea pigs, rats, large mammals, and others are used as well (Schade et al. 1996). 
The use of chickens, however, is considered a valuable alternative for a number of reasons.  
 
First, Pabs are produced in chicken egg yolk and significantly larger quantities of antibodies are 
produced per chicken in comparison to other animals, which reduces the number of animals 
needed for antibody production. Furthermore, the egg yolk technique (also referred to 
immunoglobulin Y, or IgY, technique) does not require bleeding of the chickens, an invasive 
technique used when producing antibodies in other animals.  The avoidance of this step can 
greatly reduce distress associated with Pab production (Schade et al. 1996). Also, the sites at 
which adjuvants are injected do not appear to have the marked local inflammatory response as 
is often seen in mammals. Finally, false positive reactions in certain immunchemical assays are 
unlikely. For the various welfare and scientific reasons discussed here, the use of the chicken 
egg yolk technique for Pab production should be utilized whenever possible.  
 
One main reason that many institutions do not use chickens, despite the associated 
advantages, is the lack of facilities to properly care for chickens. In this case, institutions should 
opt for outsourcing Pab production using the chicken egg yolk technique instead of carrying the 
procedures out in-house. Of course, only qualified and reputable commercial suppliers should 
be used. For those institutions that have Public Health Service (PHS) assurance, the supplier 
must be PHS-assured as well.   
 
B. It was agreed that oral immunization is preferable over injections routes. According to Hau 
and Hendriksen (2005) there are now more oral immunization choices available so that injection 
is not necessary; these include aerosol or voluntary oral intake 
 
C. Participants agreed that intramuscular (IM), intraperitoneal (IP), intrasplenic, 
intravenous (IV), and footpad injections should be discouraged. If these routes are used, strong 
scientific justification should be provided. 
 
Adjuvants that can be coadministered with antigens orally and nasally are new developments 
(Eriksson & Holmgren, 2002; Foss & Murtaugh, 2000); researchers are encouraged to monitor 
the emerging literature in this area, as oral and nasal routes of administration may produce an 
appropriate antibody response and may be preferred in regard to animal welfare. A major 
problem is that a local immunity (IgA) response is elicited rather than a humoral (IgG) response. 
 
D. If oral immunization is not used, subcutaneous (SC) and intradermal (ID) are considered to 
be acceptable routes of injection. There was some discussion and disagreement over which of 
these two routes is preferable.  
E. The chosen adjuvant should ideally induce high antibody titers in serum and/or egg yolk while 
minimizing pain and distress. Adjuvant choice should be carefully determined and pilot studies 
are suggested as one way to determine the best adjuvant for a particular immunogen or class of 
antigens. 
 
F. Recommendation: Freund’s Complete Adjuvant (FCA) may not be as problematic with regard 
to pain and distress as has been suggested and may have advantages over other adjuvants 
when used properly. However, when using FCA, it is crucial that the volume used be minimized 
(based on route of injection and animal species), the sample for injection is properly prepared, 
and the administration competently performed. Under no circumstances should an animal be 
given a second injection of FCA. 
 
G. Regardless of the adjuvant chosen, the smallest volume possible that produces an adequate 
antibody response should be used. It is recommended that very small volumes be injected into 
multiple sites for an enhanced antibody response. 
 
Workshop participants also identified a number of areas in which further research is necessary:  
 
 Determine species-specific information for welfare and pain and distress assessments 
(including behavioral data). 
 Develop alternatives to adjuvants in order to create an immune response while decreasing 
animal pain and distress 
 Create new adjuvants and immunization methods in order to decrease animal pain and 
distress. 
 Determine what role pain plays in the antibody response. 
 Examine the effects of varying amounts of mycobacteria in adjuvants in order to decipher 
preferable levels. 
 Determine if cage enrichment and group housing would simplify recognition of welfare 
problems, increase animals’ psychological well-being (Turner et al., 1997), and increase 
production of Pabs. 
 Determine whether there are pathological effects indicative of pain and distress during Pab 
production. 
 
It was emphasized that such research should, whenever possible, be “piggybacked” onto 
existing work in order to avoid the use of additional animals. 
 
The amount of scientific information on Pab production is increasing at a rapid rate; 
consequently, personnel carrying out Pab production should keep up with the literature in order 
to reduce animal pain and distress associated with this common procedure.   
 
 
Animal Models of Human Psychopathology: Anxiety 
John P. Gluck Ph.D. 
University of New Mexico 
Kennedy Institute of Ethics, Georgetown University 
 
Psychology is a broad and diverse scientific enterprise.  As a consequence, the research topics 
that make use of animals are many and include basic studies of perception, learning, cognition, 
motivation, animal communication, behavior genetics, behavioral evolution, brain/ behavior 
relationships, development, and models of human psychopathology.  Animal models of 
abnormal emotional behavior such as anxiety disorders represent some of the most 
controversial uses of animals in psychology and will be the focus of this section.  The purpose of 
this section is to provide the historical context of this research, familiarize the reader with the 
range of anxiety disorders diagnosable in humans and with a representative sample of the 
animal methods that have been used to study these disorders. The section concludes with a set 
of general questions which may be useful in facilitating a discussion between researchers and 
IACUC reviewers, with the intended outcome of refining procedures to limit animal distress and 
pain. 
  
Psychology and the Use of Animal Models of Psychopathology 
Early in the twentieth century the Nobel Prize winning physiologist Ivan Pavlov was studying 
learning mechanisms that determined how specific environmental stimuli came to be associated 
with specific behavioral responses.  Research on these “conditioning” processes made 
extensive use of dogs, sheep, pigs and goats as experimental subjects.  In the well-known 
prototypical experiment, a biologically neutral stimulus like a clicking metronome was paired 
with the insertion of food powder into the mouth of a dog.  The food powder immediately elicited 
salivation.  It was found that after a number of such pairings the sound of the metronome alone 
would call forth the salivation.  In other paradigms a neutral stimulus was paired with electric 
shock to the forelimb of a goat.  The shock would elicit a flexion of the leg, which would 
eventually be elicited by the neutral stimulus alone (see Pavlov, 1928).   
 
However, in these types of conditioning experiments it was also frequently observed that if an 
animal was tested continually, over a period of months or even years, or was required to 
discriminate between different stimuli that were very similar, the associations would eventually 
breakdown and be replaced by what was referred to as “experimental neurosis”.  For example, 
instead of a simple leg flexion the animal might begin to show exaggerated defensive 
responses, rigidity, disturbed vocalizations, and desperate attempts to escape.  These reactions 
were quite bizarre and were soon seen as challenging the Freudian perspective that suggested 
that the burden of mental illness was limited to human beings.  Researchers like Gantt and 
Liddell (see Wolpe et al. 1964) published papers and gave live demonstrations of “neurotic” 
animals that were intended to advance the claim that these complex emotional disorders could 
be studied in animals.  In other words, these observations led to a consideration that animals 
could serve as stand-in laboratory models for humans not only for physical diseases like 
infections and cancer but psychological conditions as well.  
 
Later in the twentieth century researchers like Harry F. Harlow et al. (1971) and Martin Seligman 
(1975) added to the methods of creating psychopathology in animals by developing laboratory 
analogies of traumas purported to be crucial in creating abnormal behavior in humans.  For 
example, Harlow separated monkey infants from their mothers in an attempt to replicate the 
human developmental deprivation defects emphasized by theorists such as the British 
psychiatrist John Bowlby (1988). Similarly, Seligman exposed animals to environments in which 
they were “helpless” to exert control on the delivery of aversive stimuli, thereby intending to 
create an analogy of the helpless experience of depression reported by some patients.  This 
simulation or analogy approach is still dominant in the current literature on animal models. In 
addition, with the increase in the understanding about the contributions of genetics to mental 
disorders, animal models that involve developing strains of animals with the desired behavioral 
characteristic by selective breeding or by “knocking out” genetic material suspected to be 




Animal Models of Psychopathology and the IACUC       
In general, reviews of protocols that involve animal models of psychopathology pose particular 
difficulties for the IACUC.  First, there can be no question about the need for continued 
development of effective mental health interventions.  Mental disorders affect many people 
during their lifetime, inflicting distress and disability that extract a great toll from the affected 
individuals and their families.  Second, human biochemical, post- mortem, and brain imaging 
studies have contributed mounting suggestive evidence about the existence of identifiable 
changes in neurotransmitter availability and brain architecture in people with mental disorders.  
As a consequence, the current treatment zeitgeist in psychology and psychiatry has increasingly 
come to emphasize the use of pharmacological interventions to ameliorate the clinical 
manifestations.   Therefore, research methods necessary for locating abnormal neural 
alterations, understanding the mechanisms of action of possible medications, and the screening 
of potential agents for effectiveness and safety prior to the start of human clinical trials, have 
gained priority.  Third, the development and use of animal models of human psychopathology 
has a long history and tradition in psychology that results in a somewhat entrenched positive 
presumption about their reliability and usefulness.  Fourth, the very purpose of the models is to 
produce distress to an extent that a serious psychological pathology can be said to have been 
created and then maintained for some extended period of time so that the goals of the 
experiments can be achieved.  Consequently, issues concerning the application of the three Rs 
are not at all straight forward.  Fifth, while the symptoms of human psychopathology often have 
some clearly observable behavioral changes (e.g. exaggerated startle response in Post 
Traumatic Stress Disorder, extreme avoidance of objects and places in specific phobias) 
diagnosis and treatment progress in humans is primarily based upon the reports of subjective 
experience of the patient.  Therefore the degree to which an animal model actually maps on to 
the human condition is always to some degree in question. 
 
Classification of Human Anxiety Disorders 
It has been estimated that the prevalence of mental disorders in the human adult population 
alone is approximately 20 percent, with anxiety disorders accounting for over 16 per cent of the 
total (Regier et al., 1993; Kessler et al., 1994).  Anxiety disorders in humans are manifested in a 
variety of different ways.  The authoritative Data and Statistical Manual of the American 
Psychiatric Association (DSM IV TR) lists 11 separate anxiety disorders. All share, to varying 
degrees, a set of symptoms that includes intrusive thoughts, irrational fears, feelings of dread, 
behavioral compulsions, edginess, irritability, increased startle reactions, sleeplessness, heart 
palpitations, chest pain, sweating, headaches, and rapid shallow breathing. The basic disorders 
are described as follows.  
 
1.  General Anxiety Disorder.  This disorder is characterized by high levels of worry about the 
issues of everyday life to an extent that functioning is impaired.  Physical symptoms include 
headaches, weakness, edginess, sleeplessness, and irritability. 
 
2.  Acute Stress and Post Traumatic Stress Disorder. Acute stress disorder refers to the anxiety 
symptoms that develop within the first month after exposure to an extreme trauma such as a 
violent crime like rape, murder, assault, serious motor vehicle accident, and military combat. 
The symptoms include generalized anxiety, increased startle, social avoidance, and recurrent 
thoughts or flashbacks about the experience.  If symptoms continue, post traumatic stress 
disorder is diagnosed when patients lose self-esteem, become cynical about life and 
relationships, feel permanently broken, and become vulnerable to substance abuse   
 
3.  Obsessive Compulsive Disorder. Patients experience unwanted intrusive and persistent 
thoughts that are perceived as inappropriate or even grotesque.  Compulsions are demanding 
repetitive behaviors (e.g. lock checking, hand washing) that reflect the patient’s attempt to 
control their anxiety. 
 
4.  Panic Disorder with or without Agoraphobia.  The central experience of a panic disorder is a 
very rapid onset of the physical symptoms described above coupled with fear of their 
recurrence. Agoraphobia refers to fear of situations where help or escape from a panic attack 
would be impossible or publicly humiliating. 
 
5.  Phobias.  A phobia is an intense irrational fear of a specific object (e.g. snakes, heights) or 
social situation that results in avoidance. Social phobias tend to involve powerful fears of being 
examined, judged, rejected and embarrassed while in public.  
 
Animal Models of Anxiety Disorders  
Just as there are many types of human anxiety disorders, there are many approaches to 
creating and measuring anxiety in animals for the purpose of research. However the purpose of 
the models tends to be redundant rather than capturing the diversity of the human disorders.  
Unlike in the animal models used to study pain, researchers involved in anxiety studies have not 
explicitly addressed the ethical issues raised by their research.  There has been little discussion 
in the literature of the merits of a test that allows the animal some level of control (e.g. the open 
field test) versus a model that forces the animal into an unpleasant situation from which there is 
no escape (e.g. the Vogel Drinking conflict test where the water sipper delivers a shock on a 
random schedule).  In fact, the research literature involving animal models of anxiety hardly ever 
mention the possibility that such studies might be causing distress.  This is in very marked 
contrast to the literature involving animal models of pain and probably stems from the fact that 
“anxiety” in animals is either denied altogether (e.g. Cassano, 1983) or greatly discounted as a 
source of distress.   
 
Nevertheless, Gray’s 1988 review of anxiety research (and his proposal that “anxiety” is part of 
a Behavioral Inhibition System that provides survival benefits to vertebrates) stresses the 
similarities between rodent behaviors in response to situations that produce anxiety and human 
behaviors.  He notes that anxiogenic and anxiolytic drugs produce very similar outcomes in 
rodents and monkeys to those seen in humans.   
 
Rodent models dominate this research so the discussion below is limited to their use.  As will be 
seen in the representative sample of tests presented in Table 2, the vast majority of the 
nongenetic manipulations  (Models 1-9) are based upon the strategy of  creating a conflict 
between the natural curiosity of an animal to explore novel nonsocial or social situations and the 
need to avoid dangerous and aversive situations.  Models 10-12 expose animals to traumatic 
circumstances known to have human clinical relevance.  Models 13 and 14 focus on behavioral 
markers of anxiety, and model 15 emphasizes genetic manipulations. Information on additional 
models, particularly those involving genetic manipulation, can be found in Ohl (2005).      
    
Overview 
1.  The variety of models and measures found in the literature indicates substantial theoretical 
and methodological disarray.  Specifically, there has been a dearth of research which has 
looked at the level of distress produced by the different models, or the relative usefulness of the 
various approaches, and what, if any, relationship exists between the various models and the 
array of human clinical disorders.  This is problematic from the animal welfare perspective given 
the wide variation in the level of induced distress present in the various models. 
 
2.  Because the function or “meaning” of the observed behavior is vague, validation has been 
limited to the results of pharmacological challenges.  In other words, if dosing animals with 
medications known to have reliable anti-anxiety effects in humans results in a decrease in the 
measures of animal anxiety, the model is considered validated.  According to Velucci (1989):  
(a) The animal must be sensitive to clinically effective anxiolytics in a dose-dependent manner, 
(b) the relative potencies of different agents should be similar to those seen clinically in human 
patients, (c) the tests should distinguish the effects of anxiolytic from non-anxiolytic drugs.   
While these relationships are important, the fact is that many anxiolytic medications are 
approved for a wide range of depressive and anxiety disorders; therefore, the specifications of 
this approach to validation is quite limited.   
 
3.  Given that many of these models extract such a high cost to animals, the researchers need 
to provide a high level of justification, as would be exemplified by responses to the following 
kind of questions:         
a.  Is the understanding of the human clinical entity sufficient to warrant the 
development or use of an animal model in the first place?   
b.  What are the relative scientific merits and welfare implications of studying animals 
genetically predisposed to anxiety as compared to those that are not?   
c.  In a given experiment, which of the specific anxiety disorders is being modeled?    
d.  What is the empirical and theoretical relationship of the human disorder of interest to 
the proposed animal model? Is there evidence that data from the model under study 
has advanced understanding of the condition’s etiology, physiological mechanisms, 
and/or influenced clinical practice? 
e.  Given that the models range from relatively innocuous procedures like introductions 
into an open field to those involving shock, predators, and suffocation, does the 
proposed model represent the least distressful consistent with the experimental 
goals? 
f.  Does the research team contain individuals with sufficient human clinical training and 
experience sufficient to provide meaningful design and interpretive input? 
 
Animal models of psychological disorders are particularly challenging in regards to animal 
welfare since such models often inherently cause anxiety, depression, and other states that can 
lead to suffering. There are a number of manipulations used to induce certain states, a total of 
15 are described here for the study of anxiety in rodents alone; some causing more distress 
than others. While strong justification for animal use should be the first priority when assessing 
proposed animal use, there are a number of additional important questions to ask, including 
how the costs to the animal can be minimized. It is hoped that the list of important questions 
provided here will provide a start but that those working in the field of psychology will continue to 
refine manipulations and decrease distress caused when animals are actually used.    
 
 
Refinement In Toxicology Testing: A Workshop to Promote Current Advances and 
Disseminate Best Practices 
Hosted by The Humane Society of the United States 
Andrew N. Rowan, Martin L. Stephens, and Kathleen M. Conlee  
 
Techniques that refine the use of animals for research that is painful and distressful are 
currently being developed and used in many research facilities. Often, however, this ‘in-house’ 
knowledge is not published in the technical literature nor widely disseminated throughout the 
scientific community. The Humane Society of the United States’ (HSUS) Pain and Distress 
Campaign is committed to promoting the principles of refinement and best practices by hosting 
special topic workshops and disseminating information from them. The aim is not only to further 
animal welfare and science, but also to initiate open dialogue with and amongst scientists on 
ways of eliminating pain and distress in laboratory animals. This section of Chapter 10 provides 
an overview of the presentations given at a workshop hosted by The HSUS in New Orleans, 
Louisiana on March 14, 1999 on the subject of refinement in toxicological methods.  
 
The ‘Refinement in Toxicology Testing’ workshop aimed to identify and produce guidance for 
the consistent use of humane endpoints as well as additional refinements, such as dosing 
guidelines, telemetry, and Xenogen’s imaging technique. The broad application of such 
refinements will serve to reduce and/or eliminate the pain and distress that animals might 
experience during experimental procedures. The workshop presentations focused on four areas 
of refinements in toxicology testing: (1) empirical data to determine optimal dosing volume, (2) 
the frequency and routes of administration for common toxicological procedures; (3) the adverse 
effects of toxic chemicals, and ways to limit suffering (e.g., identifying early indicators to set 
humane endpoints), and (4) behavioral/clinical assessment prior to distress and/or decline to a 
moribund condition that may indicate timing for implementation of  humane endpoints. This 




Chronic toxicity studies can require that animal subjects be exposed to varying doses of test 
agents over an extended period of time.  There is an increase in the incidence of health 
problems over time, due to both aging and the toxicity of the test agent, raising concerns about 
the welfare of the animals.   
 
Fentener van Vlissingen (The Netherlands) assessed various clinical signs and other criteria in 
507 rats exposed to a test compound in a two-year carcinogenicity study.  These included 
clinical signs (both specific and non-specific), body weight, development of masses and 
postmortem pathology.  An overall measure of “related discomfort” was determined 
retrospectively, based on both clinical and pathological observations. It was concluded that 
humane endpoints should include both specific (e.g. anemia) and non-specific (e.g. poor 
general appearance) criteria.  For example, animals categorized as exhibiting “serious 
discomfort,” were found to have significant decreases or increases in body weight.  It was also 
found that many of the animals categorized as exhibiting “serious discomfort” had only non-
specific clinical signs. 
 
The full text of Dr. Vlissingen’s paper “Retrospective evaluation of clinical signs, pathology and 
related discomfort in chronic studies,” is at 
http://www.hsus.org/animals_in_research/animal_testing/workshop_on_refinements_in_toxicolo
gy_testing/ (click on the section entitled “Chronic toxicity”). 
  
Non-Invasive Monitoring of Animal Pain and Distress 
 
Telemetry provides an opportunity for remote and intensive monitoring of an animal’s 
physiological states that provides both insights into an animal’s level of pain and distress, and 
also generates useful data highlighting and complementing other experimental results. 
Telemetry devices allow precise monitoring of heart rate, blood pressure, blood flow, body 
temperature, intraocular pressure, and other physiological variables (e.g., Lefcourt, Erez, 
Varner, Barfield, and Tasch, 1999; Dinslage, McLaren, and Brubaker, 1998). Radio-telemetry 
techniques can be applied in all commonly used laboratory animal species, from mice to 
monkeys (Kramer, 2000). 
The initial implantation of telemetry transmitters requires surgery and is, therefore, invasive.  It 
has been reported that implants of an appropriate size are well tolerated by the animals (Moran, 
et al., 1998) but there will inevitably be acute adverse sequelae that should be allowed to 
resolve prior to experimental treatment.  However, after the implantation of the telemetric 
devices, the method is non-invasive. Animals can move freely and any increase or decrease in 
body temperature, heart rate, and blood pressure, etc., can be measured without any handling 
or manipulation of the animal, thus reducing the animal’s stress and the time needed for lab 
technicians to gather data. Animals who appear during this intensive monitoring to be 
physiologically compromised from the experimental procedures, i.e., their blood pressure and 
heart rate indicate severe distress, can be euthanized. Once removed, the telemetric devices 
may be used again for other animals. 
 
In his paper presented at The HSUS workshop, Doerning (Procter & Gamble) described using 
telemetry to monitor the impact of routine husbandry and experimental procedures on rats.  The 
results indicated that cage cleaning, placement into clean cages, replacement of cages on the 
rack, and exit of a technician from the room, produced an elevation in a range of common 
physiological parameters for over two hours. Figure 1 shows the impact of cage changing on 
various variables. Animals were divided into two groups of 7 and placed in separate racks 
designated Rack 1 and Rack 2.  At 8:30 am, well into the rats’ quiet phase, animal cages were 
removed from the rack; animals were then placed in clean cages and returned to rack. The first 
arrow on the temperature graph indicates entrance into the room and is designated as 0 hour.  
The second arrow indicates when the procedure was finished and the technician left the room.  
The data is very similar between the two groups, as is the length of time it takes each parameter 
to return to basal levels.  It can be seen that the effect of a routine cage change elevates the 
physiologic parameters measured above the normal quiet phase levels for well over two hours. 
 
The effect of routine examinations was slightly less in the rats’ home cage environment than 
when they were in a novel environment. (Heart rates returned to normal after 45 minutes for 
animals examined in their home environment versus approximately 90 minutes for rats 
examined in the strange environment.) Similar results were found in related experiments 
examining changes in physiological parameters during injectable anesthesia versus injectable 
euthanasia, blood collection versus minor surgery, and exsanguination. (See also, Hubrecht, R., 
ed. (1994), A Report by the Toxicology and Welfare Working Group: Housing husbandry and 
welfare provision for animals used in toxicology studies, on the UFAW website at 
http://www.ufaw.org.uk/toxicology.php.) 
 
The full text of Dr. Doerning’s paper “Effects of Routine Animal Husbandry and Experimental 
Procedures on Physiological Parameters of Rats,” is at  
www.hsus.org/animals_in_research/animal_testing/workshop_on_refinements_in_toxicology_te
sting (click on the section entitled “Non-invasive monitoring of animal pain and distress”).  
 
Other Non-Invasive Monitoring Methods 
There are a number of new methods that reduce the amount of time animals must spend in 
experiments and that permit an earlier endpoint, reducing the level of distress experienced by 
the animal.    
 Contag (Xenogen) described a technique that uses in vivo imaging to monitor biological activity 
such as gene expression. Biological tissue is tagged with photoproteins (e.g. luciferase or green 
fluorescent protein) and the photons can be detected even when they are coming from inside 
the animal.  For example, bioluminescent tags can be attached to infectious agents and the rate 
of growth and spread of the infectious agent can be easily tracked.  Contag provided examples 
of infectious disease research that could be concluded within eight hours and long before the 
animal began to display any clinical signs. Onee advantage of using bioluminescence is that 
each animal serves as its own control and data from the same animal can be compared from 
one time point to the next, thereby reducing animal numbers and animal-to-animal variation.    
 
The full text of Contag’s paper “Refinement of Animal Models by Noninvasive Monitoring of 
Infection and Gene Expression,” is at 
www.hsus.org/animals_in_research/animal_testing/workshop_on_refinements_in_toxicology_te
sting (click on the section entitled “Other non-invasive monitoring methods”). 
  
Acute Toxicity Studies: The Search for Refinement Endpoints 
 
Schlede (Germany) discussed the issue of humane endpoints as a method of refinement in 
studies of acute oral toxicity, skin and eye irritation and corrosion, and skin sensitization.  She 
examined the results of numerous tests performed in various laboratories and reported that 
there was a large variation in clinical signs documented by laboratories, as well as an enormous 
number of combinations of clinical signs observed.  Clinical signs observed in animals that 
eventually died during the testing were examined to determine if they were “alert signs” for 
impending death. For example, in acute oral toxicity testing, convulsions, lateral recumbency 
and tremors were found to be ‘alert signs’ for the impending death of rats.  However, Schlede 
reported that there was no obvious single sign that could be reliably used to alert the toxicologist 
to proceed with euthanasia.  
 
The full text of Schlede’s paper “Humane endpoints in toxicity testing,” is at 
www.hsus.org/animals_in_research/animal_testing/workshop_on_refinements_in_toxicology_te
sting (click on the section entitled “Acute toxicity studies: the search for refinement endpoints”). 
 
Dosing Data and Volume 
 
Smith (United Kingdom) introduced a draft ‘best practice’ guide on the administration of 
substances in preclinical toxicology studies. Dr. Smith presented details of the guide, including 
the guide’s objectives, factors affecting the development of the guide, useful tables of best 
practice administration volumes and routes for common laboratory species, as well as a 
“decision tree” (see Figure 2) for selecting the optimal vehicle of delivery. 
 
Smith emphasized the correlations between refinement, validity of scientific data and ethical 
concerns. An example of a refinement technique is his recommendation that small-scale pilot 
studies be carried out on any new formulation before committing to larger-scale studies.   
 
Richmond (United Kingdom) presented a summary of findings from the British Home Office on 
elements of standardizing procedures and identifying best practices in toxicology testing within 
Britain. He offered refinements in terms of recommended limits on dosing volumes per species, 
frequency and route. Table 3 lists Home Office guidelines regarding limit volumes for 
administration of substances. However, this guide is in the process of being revised following 
the draft guide discussed by Smith.  
 
The full texts of the above two papers entitled “Dosing limit volumes: A European View’ and 
“Dosing limit volumes: The United Kingdom View-Past and Present,” is at 
www.hsus.org/animals_in_research/animal_testing/workshop_on_refinements_in_toxicology_te
sting (click on the section entitled “Dosing data and volume”).  
 
While not all areas regarding the use of animals in toxicity studies are addressed here, the 
information from this workshop provided some general principles that should be considered and 
applied, regardless of the specific use of animals. For example, the way in which a substance is 
administered contributes to the suffering that the animal may experience; therefore the 
procedure used should be carefully considered and continually refined. How the animals are 
observed, monitored and how information regarding their welfare is collected, such as the use of 
telemetry described here, is also critically important in terms of minimizing pain and distress and 
establishing humane endpoints. 
 
Finally, a recent report by the National Academy of Science emphasized a vision for the future 
of toxicity testing that would not include the use of animals and would instead use new methods 
in computational biology and a comprehensive array of in vitro tests based on human biology. 
Given how rapidly the field of toxicology is developing, those using animals for this purpose are 
encouraged to keep abreast of new developments that not only refine the use of animals, but 
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